Developing B and T cells assemble their antigen receptor molecules from component gene segments by a series of genomic rearrangement events collectively termed V(D)J recombination. Two genes involved in this assembly process, RAG) and RAG2, were identified as being the only genes that need to be introduced into fibroblasts to induce recombinase activity (1, 2). A targeted disruption of either RAG gene in transgenic mice results in the complete absence of V(D)J recombination, confirming the critical role ofeach gene in the reaction (3, 4).
coding a protein of moecuar weight 58,000 that int s specifly with RAG-i. The Developing B and T cells assemble their antigen receptor molecules from component gene segments by a series of genomic rearrangement events collectively termed V(D)J recombination. Two genes involved in this assembly process, RAG) and RAG2, were identified as being the only genes that need to be introduced into fibroblasts to induce recombinase activity (1, 2) . A targeted disruption of either RAG gene in transgenic mice results in the complete absence of V(D)J recombination, confirming the critical role ofeach gene in the reaction (3, 4) .
Coexpression of RAG-1 and RAG-2 is restricted to immature cells of the lymphoid lineage (2), thereby explaining why V(D)J recombination is limited to pre-B and pre-T cells (1, 2) . However, it is also clear that other factors must be involved in the recombination reaction. Such factors need not be specific for V(D)J joining, but could instead play multiple roles in the cell and be recruited by the V(D)J recombination machinery. Examples of such factors include those defined by the mouse scid mutation (5) and by mutations in CHO (Chinese hamster ovary) cells which have defects both in V(D)J recombination and in some aspect of general DNA repair (6) (7) (8) (9) (10) . None of these factors have been cloned, and their relationships to RAG-1 and RAG-2 are unclear.
To identify other factors that might play a role in V(D)J recombination, we used the yeast two-hybrid assay to find proteins that interact with RAG-1. In screening a cDNA library derived from HeLa cells, we were looking for widely expressed factors with which RAG-1 might interact to induce V(D)J recombination. In this paper we present one such factor, Rchl (Rag cohort), which interacts specifically with RAG-1. A truncated form of Rchl reduces V(D)J recombination in vivo. 1 1 MATERIAL AND METHODS Plamids and Srains. The plasmids pJG4-5 and pL202Pl have been described previously (11) (12) (13) . The RAG-1 acidic activation construct, pLAR1, contains the entire RAG) structural gene and is the result of a three-part ligation of the Nco I-Sal I fiagment from LG-6 [a derivative of M2SK (1) 5 x 106 independent tryptophansynthesizing transformants of SKY34, a strain expressing pLDR1, were generated from a HeLa cDNA fusion library (13) that has an estimated complexity of 106. Then 5 x 107 cells were diluted into minimal media and plated on galactose plates lacking leucine. All resulting colonies (approximately 300) were picked after 4 days and streaked out on glucose plates lacking uracil, tryptophan, and histidine to select for the relevant plasmid markers under noninducing conditions. This master plate was replica-plated to test for transcription from the two reporter constructs-e.g., on plates containing RAG-1 and RAG-2 Fail to Interact in the Two-Hybrid Assay. Given the requirement for both RAG-1 and RAG-2 in V(D)J recombination, we first used the two-hybrid assay to ask ifan interaction between RAG-1 and RAG-2 could be detected. Plasmids expressing LexA-RAG-1, LexA-RAG-2, Activ-RAG-1, and Activ-RAG-2 fusion proteins were tested singly and in combination for their ability to activate transcription from the two reporter constructs. Neither LexA fusion protein activated transcription on its own. While expression of the four fusion products was confirmed by Western blot (data not shown), no interaction between RAG-1 and RAG-2 or of either protein with itself was detected. A strain containing LexA-CDC2 and Activ-CKS2 was tested in parallel and demonstrated a strong positive interaction as expected. There are three possible interpretations of this observation: (i) these proteins do not interact; (ii) they do interact, but the proteins are not appropriately expressed in yeast, or the interaction is too weak for detection; or (iii) another factor(s) that is missing in yeast normally mediates an interaction between RAG-1 and RAG-2. If this third possibility is correct, it might be possible to use the two-hybrid assay to identify this missing bridging factor.
Isolation of RCHL. To identify factors expressed in fibroblasts that might be recruited by RAG-1 for the induction of V(D)J recombination, we searched through a library constructed from acidic activation sequences fused with HeLa cell cDNA (13) . A yeast strain expressing LexA-RAG-1 was transformed with the HeLa cell library to generate 5 x 106 independent transformants. Cells containing candidate RAG-1 interactors were identified by their ability to grow in the absence ofleucine after induction on galactose. Ofthe 300 colonies that passed this initial selection, 25 contained plasmids that induced transcription in a galactose-dependent fashion from both the LEU2 and lacZ reporter constructs. The 25 plasmids could be divided into three families by DNA hybridization, and the corresponding genes were named RCHJ, RCH2, and RCH3. The 15 plasmids containingRCHl fell into six different size categories, indicating that at least 6 independent RCHI transformants had been recovered from the library.
Specificityof Interaction. The specificity of the interaction between Rchl and RAG-1 was tested by introducing the longest and shortest Rchl derivatives [Rchl-(33-529) and Rchl-(244-529), respectively] into yeast cells containing different LexA fusion proteins and assaying transcriptional activation ( Table 1 ). The interaction with RAG-1 was indeed extremely specific, as transcriptional activation was not observed with 10 other proteins fused to LexA. Further, we Different Rchl derivatives (amino acids present are indicated in parentheses) were tested for their ability to interact with the various LexA fusion proteins listed. An acidic activation construct not carrying a fusion partner (pJG4-5 vector alone) is included in each set as a control. Strains carrying the indicated LexA or activation fusion proteins were tested in the presence of glucose or galactose for their ability to grow in the absence of leucine (Leu+). Growth was assessed after 4 days: + = growth, -= no growth. Additionally, 13-galactosidase (LacZ) levels (average of three independent transformations, in standard units) were determined. The ratio of 3-galactosidase activity under inducing (galactose) versus noninducing (glucose) conditions is indicated in the last column. The results with 10 different LexA fusion proteins (fusion partners: RAG-2, Myc, Max, Cdk2, CD13, Tr, Car, Fus3, Bcd, and Cdc2) were averaged, and this average value is indicated by *. The highest ratio of LacZ expression in glucose compared with galactose, within this group of 10 proteins, was a value of 2.1 for LexA-Myc tested with Rchl-(244-529). Descriptions of the LexA fusion proteins used in addition to RAG-1 and RAG-2 can be found in ref. 12 (1) , and the N-terminal coding and 5' untranslated sequence was determined (Fig. 1) . The first methionine in the sequence is embedded in a near consensus Kozak sequence and is downstream of stop codons in all three frames, suggesting that it is the authentic initial codon. Other portions of the mouse cDNA were sequenced and found to encode a protein so nearly identical to the predicted human Rchl that the remaining sequence of the mouse cDNA was not determined. A composite sequence from the mouse and human data was used for sequence comparisons (see below). As was not surprising given the strong sequence similarity between Rchl and yeast SRP1 (see below), RCHI hybridizing sequences were found in chicken and frog at a stringency comparable to that seen for RAG] (data not shown). Sequence comparison with the BLAST program (21) revealed a striking degree of similarity between RCHI and a yeast gene, SRPI, that was identified as a suppressor of temperature-sensitive mutations in RNA polymerase I (22) . These two protein sequences are 47% identical and, allowing for conservative substitutions, are 60% similar (Fig. 2) . Strikingly, both proteins contain eight nonidentical repeats of a 42-amino acid sequence (Fig. 2) . In SRP1, two of eight repeats deviate from the 42-amino acid length, with one containing 43 amino acids and one 45. These same repeats in Rchl are also longer, containing in both cases 43 amino acids, with the additional amino acids in the same position as in SRP1. One other repeat in Rchl has an additional 5 amino acids. The amino acids showing the greatest degree of conservation between human Rchl and yeast SRP1 are the same amino acids that are conserved between internal repeats. More importantly, individual repeat sequences are more highly conserved between human and yeast than be- 
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Rchl is 47% identical to SRP1 and contains eight degenerate internal repeats. An alignment between Rchl and SRP1 was prepared by using the GCG BESTFIT program (23) . Four gaps indicated by dots or subscripted amino acids were introduced to facilitate the alignment. Identities are indicated by vertical lines, and conservative substitutions are indicated by double dots. The N-and C-terminal highly charged regions are shown separated from the internal repeats. A consensus sequence for the internal repeat structure based on the repeats from both proteins is shown. The probability score assigned by the BLAST program (21) for the sequence similarity identified between SRP1 and Rchl was 2.9 x e-84. tween repeats within each protein. Those amino acids not conserved between repeats are also less conserved between human and yeast. A consensus repeat based on the one proposed for SRP1 (22) , but including Rchl sequence information, is shown in Fig. 2 . In both SRP1 and Rchl, the repeated sequences are flanked by sequences rich in charged residues, and the sequence similarity between the two proteins extends to these flanking regions as well. Taken together, these data strongly suggest that RCHI is the human homologue of yeast SRP1.
Expression Pattern and Chromosomal Llzton. The expression of RCHI in various cell types was determined by RNA hybridization. A single predominant-RNA species with an approximate length of2 kb was observed in all the cell lines examined, including the pre-B-cell lines 22D6 and 38B9, the mature B cells WEHI231 and MPC11, the myeloma cell S194, the pre-T-cell 2017, the mature T cells rlMll and EL4, the fibroblastoid cell lines NIH-3T3 and 16B (an NIH-3T3 derivative expressing RAG-1 and RAG-2), and HeLa cervical carcinoma cells related to the cells from which the library was derived. The level of expression when normalized to human glyceraldehyde-3-phosphate dehydrogenase was comparable in all samples (representative data are shown in Fig. 3 (24) . Further, none of the CHO cell mutants described that affect both DNA repair and V(D)J recombination have defects mapping to human chromosome 17 (9) . Thus, RCHI does not appear to represent a gene previously implicated in V(D)J recombination. ] had little effect. Recombination frequencies were either slightly higher or the same as in controls (Fig. 4) . This result might have been expected, given that HeLa cells already express Rchl mRNA. However, we found that Rchl-(244-529), a truncated derivative that interacts with RAG-1, decreased the recombination frequency. Because the effect was not large, three different plasmid preparations of the truncated clone were used in seven independent transfections, each trial was done in duplicate or triplicate, and several different plasmid preparations of the full-length Rchl clone and the CDM8 control were also used. The decrease was repeatably 2-to 3-fold compared with the vector-only control. The ratio of recombination frequencies for parallel transfections receiving Rchl-(33-529) versus Rchl-(244-529) (Fig. 4) indicates that overexpression of the truncated clone yields on average recombination frequencies Y3 of those with the nearly full-length derivative.
DISCUSSION
We have identified a gene whose product interacts with the RAG-1 protein in the two-hybrid assay. The highly specific nature of the RAG-i-Rchl interaction argues against an The decreased recombination caused by a truncated derivative of Rchl suggests that Rchl is involved in V(D)J recombination. Although we cannot exclude the possibility that the truncated protein reduces recombination indirectly, it is important to note that Rchl was identified by an entirely independent assay that involves its ability to specifically interact with RAG-1 in yeast. It seems unlikely that these two distinct properties of Rchl are merely coincidental. Further, if Rchl merely interacted with RAG-1 and prevented it from functioning normally, but played no role in V(D)J recombination, the full-length and truncated proteins should have had the same effect. Instead the nearly full-length and presumably functional protein does not inhibit the recombination activity, whereas the truncated protein acts as a dominant negative. Thus, the specific interaction between Rchl and RAG-1 appears likely to be involved in the induction of V(D)J recombination.
Although the role of Rchl in V(D)J recombination remains to be elucidated, the repeat structure of Rchl and its homology with SRP1 may provide useful clues. Biochemical fractionation indicates that SRP1 is localized to the nucleus, and at least some of the protein appears to be associated with the insoluble nuclear matrix/lamina/pore fraction (22) . Immunofluorescence microscopy of SRP1 in yeast supports this conclusion, as a punctate staining pattern is seen near the nuclear envelope, perhaps at the nuclear pores (22) . While no other known proteins have the same repeat structure as SRP1 and Rchl, other proteins with multiple internal repeats (Schizosaccharomyces pombe nuc2+, S. cerevisiae Cdc23, and ankyrin and members of the ankyrin repeat family) are thought to form structures within the nucleus and to be associated with integral membrane proteins (discussed in ref.
22 and references therein). Although SRPI was isolated as a suppressor of temperature-sensitive mutations in RNA polymerase I, no biochemical evidence of a direct interaction between SRP1 and RNA polymerase I was found, nor was SRP1 found in the nucleolus (22) . Thus, it was suggested that SRP1 may play some structural role in the nucleus which then indirectly influences RNA polymerase I function. Interestingly, SRP1 is an essential gene in yeast.
By analogy with SRP1, the Rchl protein may be associated with matrix/membrane structures in the nucleus. The recent report that overexpressed RAG-1 gives a punctate staining pattern in tissue culture cells is interesting in this regard (26) . It is appealing to speculate that Rchl might serve to bring RAG-1 and other components of the recombinational apparatus together into an active complex associated with specific structures within the nucleus. The modification and rejoining of the cut ends during recombination could be facilitated if they were held in such a structure.
